Funding, M&A and exec moves matched to your market — guaranteed to pay for itself in a year, or we refund it.See plans →

Supplement Maker Timeline Raises $66M Amid Longevity Wave

PRIVATEJan 25, 2024•over 2 years ago

Amount Raised

$66 Million

Round Type

Funding Round

LausanneBiotechnology Research

Investors

NestléL’oréal

Description

Timeline has raised $66 million in a Series D financing round, with strategic investments from L’Oréal and Nestlé. The funding will go towards expanding Timeline’s product categories and markets across food, beauty, and health, remaining longevity-focused.

Company Information

Company

Timeline

Location

Lausanne, Vaud, Switzerland

About

Timeline (parent company Amazentis) is a Swiss longevity biotech positioned at the intersection of the consumer health, nutrition, and beauty sectors. With more than a decade of expertise in aging science research, Timeline seeks to push the boundaries of human healthspan, contributing to a future where everyone can live longer, healthier lives. The company is backed by over 15 years of research by distinguished scientists, multiple clinical studies, and over 50 patents. Nestlé Health Science and L'Oréal are investors in the company.

Don't miss Timeline's next move

Get an email the moment Timeline raises, hires an exec, or expands — usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you

1 contact

Predictive Intelligence

Strategic

ML-powered predictions for Timeline's next move

Learn about Strategic plan

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech